A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma - Lopez, Juanita Suzanne; Haefliger, Simon; Plummer, Ruth; Clement, Paul M.; Jeffry Evans, Thomas R.; Läubli, Heinz; Roth, Patrick; Kristeleit, Rebecca; Brazil, Lucy; Tabatabai, Ghazaleh; Wick, Antje; Wunderlich, Benjamin; et al. (Cell reports. Medicine, 2025)
Online verfügbar: 17. Juni 2025, Artikelversion: 17. Juni 2025